Microglia-specific AIM2 inflammasome hyperactivation was demonstrated in the APP/PS1 AD model (87) and found to contribute to synaptic and cognitive impairments in an Aβ injection AD model (88). The gene discussed is AIM2; the disease is Alzheimer disease.